ACSS2 and neoplasm: Treatment of ex vivo MDA-MB-231BR (Figure 7A) or 4T1BR (Supplementary Figure S3C) tumor bearing brain slices with ACSS2 inhibitors AD-5584 and AD-8007 significantly reduced tumor growth of preformed tumors, suggesting induction of cell death compared to controls.